Form 8-K - Current report:
SEC Accession No. 0001610618-20-000061
Filing Date
2020-11-30
Accepted
2020-11-30 16:17:00
Documents
14
Period of Report
2020-11-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdtx-20201130.htm   iXBRL 8-K 33885
  Complete submission text file 0001610618-20-000061.txt   183358

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20201130.xsd EX-101.SCH 2418
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20201130_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20201130_def.xml EX-101.DEF 1647
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20201130_lab.xml EX-101.LAB 26303
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20201130_pre.xml EX-101.PRE 13731
7 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20201130_htm.xml XML 11654
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 201358318
SIC: 2836 Biological Products, (No Diagnostic Substances)